Business Context and Reporting Period
This Form 8-K is a current report filed by OvaScience, Inc. (not Tempest Therapeutics, Inc.) on November 3, 2016. The filing serves to announce the company's financial results for the quarter ended September 30, 2016. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being located in the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that financial results for the quarter ended September 30, 2016, were announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It notes that the information in this report (including the press release) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the correct registrant name is OvaScience, Inc., as the input metadata incorrectly listed "Tempest Therapeutics, Inc."
- Locate and review Exhibit 99.1 (Press Release dated November 3, 2016) to obtain actual financial figures for the quarter ended September 30, 2016.
- Confirm the legal status of the press release as "furnished" rather than "filed" for liability purposes under Section 18 of the Exchange Act.